Anavex Life Sciences Corporation (NASDAQ:AVXL) price on Wednesday, May 09, fall -3.39% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $3.71.
A look at the stock’s price movement, the close in the last trading session was $3.84. Turning to its 52-week performance, $10.45 and $3.25 were the 52-week high and 52-week low respectively. Overall, AVXL moved -15.49% over the past month.
Anavex Life Sciences Corporation’s market cap currently stands at around $304.63 million.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AVXL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
AVXL’s current price about -3.53% and -17.81% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.85, while 7-day volatility ratio is 4.03% and 5.69% in the 30-day chart. Further, Anavex Life Sciences Corporation (AVXL) has a beta value of 0.66, and an average true range (ATR) of 0.23.
If we refocus on Anavex Life Sciences Corporation (NASDAQ:AVXL), historical trading data shows that trading volumes averaged 1.27 million over the past 3 months. The company’s latest data on shares outstanding shows there are 82.07 million shares.
The 3.16% of Anavex Life Sciences Corporation’s shares are in the hands of company insiders while institutional holders own 30.65% of the company’s shares. Current price change has pushed the stock -60.15% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AVXL stock continues to rise going into the next quarter.